The IHC profile of ACC is defined by its intense reactivity to cytokeratins CKAE1/AE3, CAM 5.2 and EMA and by its absence of immunoreactivity to the S100 protein, chromogranin and vimentin. This evidence concerns the gene VIM and adrenal cortex carcinoma.